Close
Solutions
Online Inquiry
Global Services

CAR-Specific Monoclonal Antibody Development Service for CAR Expression Detection

Online Inquiry

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

With unrivaled expertise and experience in antibody discovery and development, Creative Biolabs has developed an advanced platform to develop the CAR specific monoclonal antibodies. The CAR-specific antibody will help to detect the CAR expression during CAR in vitro assays. Our scientists are dedicated to comprehensive services for our one-stop CAR-T cell development.

Background

Immunotherapies have achieved unparalleled success in recent years, especially the chimeric antigen receptor (CAR) T therapy. According to the data in ClinicalTrial.gov, more than 600 CAR-T cell therapy programs are under clinical trials. During CAR-T cell therapy discovery, CAR detection is needed in the following stages.

  • CAR In Vitro Expression Test
  • For CAR engineered T cells or other cell types, CAR expression needs to be confirmed.

  • CAR In Vivo Distribution Test
  • After CAR-T cell infusion in animal models, bio-distribution of CAR-T cell needs to be tested.

  • CAR Distribution Test in Clinical Trial
  • Since CAR-positive T cell is related to anti-tumor activity, CAR expression and percentage of CAR-positive T cells after CAR-T cell infusion are critical.

CAR-specific Monoclonal Antibody Development to Detect CAR Expression

To facilitate CAR detection in all stages during CAR-T cell therapy discovery and development, Creative Biolabs has developed a specialized team to develop CAR-specific anti-idiotypic monoclonal antibodies. We are committed to developing anti-CAR mAbs with high sensitivity and high specificity. All anti-CAR mAbs will be validated before delivery to ensure high performance. Here are some featured CARs under frequent investigation. Our services cover the following CARs, but not limited to these. If you have any specific requirements, please just reach out to our team for an exclusive conversation.

For Hematologic Tumors
Anti-CD19 CARs Anti-CD20 CARs Anti-CD22 CARs Anti-CD23 CARs Anti-CD30 CARs
Anti-CD33 CARs Anti-CD38 CARs Anti-CD70 CARs Anti-CD123 CARs Anti-CD44v6 CARs
Anti-BCMA CARs Anti-CD138 CARs Anti-ROR CARs Anti-NY-ESO-1 CARs Anti-FAP CARs
Anti-NKG2D CARs Anti-FLT3 CARs Anti-CLL1 CARs Anti-Lewis Y CARs etc.
For Solid Tumors
Anti-CEA CARs Anti-CD133 CARs Anti-c-Met CARs Anti-EGFR CARs Anti-EPCAM CARs
Anti-GD2 CARs Anti-FRα CARs Anti-GPC3 CARs Anti-GUCY2C CARs Anti-HER2 CARs
Anti-ICAM-1 CARs Anti-IL13Rα2 CARs Anti-IL11Rα CARs Anti-KRAS CARs Anti-MAGE CARs
Anti-MUC1 CARs Anti-PSCA CARs Anti-CSPG CARs Anti-IL-13R CARs Anti-MSLN CARs
Anti-VEGFR CARs Anti-PSMA CARs Anti-WT1 CARs Anti-CD24 CARs etc.
We can offer CAR-specific antibody development services for various kinds of CARs, please reach out to us for further communication.

Highlight Features

  • Precision: With extensive experiences in antibody development, our scientists are committed to providing the monoclonal antibodies that meet or exceed your specifications.
  • Accuracy: With our expertise and advanced platforms, we are confident in CAR-specific antibody development at high speed and efficiency.
  • Flexibility: Our team has extensive CAR experiences including every step during our one-stop CAR solutions. No matter you need the antibody development service only, or the one-stop CAR solution, we are ready for support.
  • Customization: We offer CAR-specific antibody development for all kinds of CARs.

With our skilled and advanced antibody development platforms, Creative Biolabs is confident to be the best option for our clients. If you need monoclonal antibody to detect the CAR, let's get the conversation started for your requests. Please feel free to contact us and our scientists will offer the best assistance at the earliest convenience.

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.